The Centre for Clinical Practice develops clinical guidelines which form recommendations on the appropriate treatment and care of people with specific diseases and conditions within the NHS. They are based on the best available evidence. Guidelines help health professionals in their work, but they do not replace their knowledge and skills
NICE public health guidance makes recommendations for England on what is known from research and practice about the effectiveness and cost effectiveness of interventions and broader programmes, including the systems in which they are delivered, and the methods used to deliver them.
NICE public health guidance is relevant to health professionals working in clinical and community settings, and commissioners, managers and team leaders with responsibility for health improvement in the NHS, local authorities, schools, and public, private and voluntary sectors. It is also relevant to people interested in improving their own health or the health of their children or other people they care for, and to the wider community.
|Scoping workshop:||12 November 2012|
|Consultation on draft scope with stakeholders:||29 November 2012 - 10 January 2013|
|Consultation on draft guideline with stakeholders:||18 May - 30 June 2015|
|Publication date:||December 2015|
|Centre for clinical practice lead:||Sarah Willett|
|Communications manager:||Phil Ranson|
|Guidelines commissioning manager:||
|Guidelines coordinator:||Paula O'Grady|
|Patient involvement lead:||Erin Whittingham|
|Implementation lead:||Louisa Regan|
|Guidelines Development Group:||The Guideline Development Group (GDG) oversees the development process.|
|25 June 2013||
The Centre for Public Health (CPH) is currently carrying out a call for evidence to enable stakeholders to submit any information that may be relevant to the CPH team at NICE to inform it’s evidence reviews. The CPH is particularly interested in receiving information on any studies that are in-progress, unpublished, in-press or that have recently been published, or grey literature that relates to the review areas and questions outlined in the final scope.
For more information and to access the forms for evidence submissions, please visit the call for evidence webpage.
|February 2013||The final scope defines what aspects of care/service delivery are covered by the guideline and to whom it applies. Comments that were made by registered stakeholders during the draft scope consultation can be seen in the draft scope consultation comments table. The Guideline Development Group (GDG) oversees the development process.|
|January 2013||The Internal Development team and the Institute are in the process of agreeing details of the workplan including how the development will progress, the membership of the Guideline Development Group and timescales.|
|January 2013||Consultation on the draft scope is complete and the scope is being modified in the light of the comments received. The final scope will be posted here on the website. It will define what aspects of care/service delivery the guideline will cover and to whom it will apply.|
|29 November 2012||The draft scope is out for consultation with stakeholders. The scope defines what aspects of care the guideline will cover and to whom it will apply. If you wish to comment, you need to do so via one of the registered stakeholder organisations listed, by the deadline shown.|
|20 November 2012||The first draft of the scope is currently in preparation. The scope will define what aspects of care the guideline will cover and to whom it will apply.|
|25 September 2012||The NCC is currently looking to recruit a chair for the Guideline Development Group (GDG)|
|October 2012||Recruitment for the Guideline Development Group chair closed on 24 October 2012|
|February 2012||We have commissioned the Internal Clinical Guideline Programme to update the guideline on Tuberculosis which was published in March 2011. For further information on updating guidelines please see Developing NICE guidelines: the manual.|